Tricyclic Antidepressants and Non-Hodgkin Lymphoma
Author(s) -
Susanne Oksbjerg Dalton,
Aslak Harbo Poulsen,
Mette Nørgaard,
Joseph K. McLaughlin,
Christoffer Johansen,
Søren Friis
Publication year - 2008
Publication title -
epidemiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.901
H-Index - 173
eISSN - 1531-5487
pISSN - 1044-3983
DOI - 10.1097/ede.0b013e318176bf98
Subject(s) - tricyclic , medicine , incidence (geometry) , medical prescription , poisson regression , rate ratio , tricyclic antidepressant , confidence interval , lymphoma , antidepressant , non hodgkin's lymphoma , relative risk , pharmacology , population , environmental health , physics , hippocampus , optics
An increased risk of non-Hodgkin lymphoma (NHL) has been reported among long-term users of tricyclic antidepressants.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom